On July 31,2014 NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infectives, today reported second quarter 2014 financial results and provided a clinical and commercialization update. NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) belongs to Healthcare sector. Its weekly performance is 22.55%. On last trading day company shares ended up $1.25. NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) distance from 50-day simple … Continue reading Today’s Hot List: NovaBay Pharmaceuticals (NYSEMKT:NBY), IHS (NYSE:IHS), Solitario Exploration (NYSEMKT:XPL), CIRCOR International, (NYSE:CIR), Hersha (NYSE:HT)